Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer

Circulating tumor DNA (ctDNA) can be a prognostic biomarker for non-muscle-invasive bladder cancer (NMIBC); however, targeted sequencing has not been performed to detect ctDNA in NMIBC. We applied targeted sequencing based on an 861-gene panel to determine mutations in tumor tissue DNA and plasma ct...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinghua, Dai, Daofeng, Tian, Junqiang, Li, Lifeng, Bai, Jing, Xu, Yaping, Wang, Zhiping, Tang, Aifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114939/
https://www.ncbi.nlm.nih.gov/pubmed/33996580
http://dx.doi.org/10.3389/fonc.2021.657483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114939/
https://www.ncbi.nlm.nih.gov/pubmed/33996580
http://dx.doi.org/10.3389/fonc.2021.657483

Ejemplares similares